TheraRadar
← Back
Data updated: Jul 17, 2026

ALLEGIANCE HLTHCARE

Pharma
Pharmaceuticals

ALLEGIANCE HLTHCARE is a pharmaceutical company with 1 FDA-approved products.

1989
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules

ALLEGIANCE HLTHCARE's Key Drugs

ALLEGIANCE HLTHCARE's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

ALLEGIANCE HLTHCARE's Recent FDA Approvals

New NDA/BLA approvals for ALLEGIANCE HLTHCARE over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

ALLEGIANCE HLTHCARE's Therapeutic Areas

Disease areas where ALLEGIANCE HLTHCARE has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

ALLEGIANCE HLTHCARE Pipeline Snapshot

Active clinical trials for ALLEGIANCE HLTHCARE across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling